UNICEF has awarded a contract to GSK, a pharmaceutical firm, for the first-ever supply of malaria vaccine with a value of up to $170 million. This grant will make 18 million doses of RTS,S available for next three years, potentially saving thousands of lives each year, UNICEF stated. The vaccine is a result of 35 years of research, it added.